Thursday, October 22, 2020
Home Clinical Data Management Introductory Session on Clinical Data Management

Introductory Session on Clinical Data Management

Hello everyone,

Introductory Session on Clinical Data Management for Freshers is going to be held on Aug-30-2020 (Sunday) from 3:00pm -5:00pm. Please confirm your presence on our mail Id: [email protected] as we are unable to send much messages on linkedIn.

- Advertisement -

Details of Zoom meeting Id and Passcode will be send to each participants before two days of session held.

Requesting each interested participants to have a look on these terminology so that it will be easy for you to understand our session well.

Clinical Research Coordinator
https://www.lifepronow.com/2020/05/16/beginners-guide-to-clinical-research-coordinator/

Basics of case report form
https://www.lifepronow.com/2020/07/07/basics-of-case-report-form/

Clinical Research Associate
https://www.lifepronow.com/2020/05/10/clinical-research-associate-role-responsibilities-skills-and-salary/

Note: This session is only for freshers,
kindly paste your LinkedIn profile Link in subject column

LEAVE A REPLY

Please enter your comment!
Please enter your name here

9 + 6 =

Most Popular

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in...

Forxiga recommended for approval in the EU by CHMP for heart failure

October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which...

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination...